Gastrointestinal
Colon
- CTSU C80702: A Phase III Trial of 6 versus 12 treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for patients with Resected Stage III Colon Cancer
Esophageal/GE Junction
- SWOG S1201: Combination Chemotherapy in Treating Patients With Advanced or Metastatic Esophageal Cancer, Gastric Cancer, or Gastroesophageal Junction Cancer
Pancreas
- SWOG 1115: Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
For more information, contact Cheryl Patz, RN, OCN, CCRC, at (360) 715-4133.
